ZP4207 (Dasiglucagon)

dasiglucagon · Zealand Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZP4207 (Dasiglucagon), covering 2017-04-21 to 2017-04-21. Get the full timeline:

Most recent: Clinical Trial Update: ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon [Phase 2]